0001562180-24-005715.txt : 20240715 0001562180-24-005715.hdr.sgml : 20240715 20240715160855 ACCESSION NUMBER: 0001562180-24-005715 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240606 FILED AS OF DATE: 20240715 DATE AS OF CHANGE: 20240715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bilenker Joshua H. CENTRAL INDEX KEY: 0001612312 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39941 FILM NUMBER: 241117354 MAIL ADDRESS: STREET 1: C/O LOXO ONCOLOGY, INC. STREET 2: ONE LANDMARK SQUARE, SUITE 1122 CITY: STAMFORD STATE: CT ZIP: 06901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sana Biotechnology, Inc. CENTRAL INDEX KEY: 0001770121 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: (206) 701-7914 MAIL ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98102 4/A 1 primarydocument.xml PRIMARY DOCUMENT X0508 4/A 2024-06-06 2024-06-07 false 0001770121 Sana Biotechnology, Inc. SANA 0001612312 Bilenker Joshua H. C/O SANA BIOTECHNOLOGY, INC. 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 true false false false false Stock Option (Right to Buy) 7.36 2024-06-06 4 A false 65000.00 0.00 A 2034-06-05 Common Stock 65000.00 65000.00 D This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired. The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. ("Sana"), provided that the reporting person provides continuous service to Sana through such date. /s/ Julie Shah, Attorney-in-Fact for Joshua H. Bilenker 2024-07-15